SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-011740
Filing Date
2024-02-09
Accepted
2024-02-08 18:18:29
Documents
17
Period of Report
2024-02-08

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea193148-6k_immuron.htm 6-K 13509
2 INVESTOR WEBINAR PRESENTATION ea193148ex99-1_immuron.htm EX-99.1 19298
3 GRAPHIC image_001.jpg GRAPHIC 1254
4 GRAPHIC ex99-1_001.jpg GRAPHIC 5145
5 GRAPHIC ex99-1_002.jpg GRAPHIC 3366
6 GRAPHIC ex99-1_003.jpg GRAPHIC 6495
7 GRAPHIC ex99-1_004.jpg GRAPHIC 292294
8 GRAPHIC ex99-1_005.jpg GRAPHIC 481620
9 GRAPHIC ex99-1_006.jpg GRAPHIC 330133
10 GRAPHIC ex99-1_007.jpg GRAPHIC 476761
11 GRAPHIC ex99-1_008.jpg GRAPHIC 418488
12 GRAPHIC ex99-1_009.jpg GRAPHIC 568962
13 GRAPHIC ex99-1_010.jpg GRAPHIC 562819
14 GRAPHIC ex99-1_011.jpg GRAPHIC 318390
15 GRAPHIC ex99-1_012.jpg GRAPHIC 462046
16 GRAPHIC ex99-1_013.jpg GRAPHIC 683858
17 GRAPHIC ex99-1_014.jpg GRAPHIC 202327
  Complete submission text file 0001213900-24-011740.txt   6663826
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 24610559
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)